MaxCyte, Inc.

MaxCyte is the leader in providing clinical/commercial cell modification technologies and unparalleled expertise to the global leader in the life sciences. MaxCyte's revolution transfection platform enables the discovery, development, manufacturing and delivery of innovative and important therapeutic products for a wide range of serious diseases.